MedPath

Effects of adrenomedullin in catheter ablation of persistent atrial fibrillatio

Not Applicable
Conditions
persistent atrial fibrillation
Registration Number
JPRN-UMIN000031865
Lead Sponsor
niversity of Miyazaki
Brief Summary

We enrolled 3 patients of adrenomedullin group and 4 patients of control group. Any statistically significant differences were not observed between adrenomedullin group and control group. We continued this study as Specified Clinical Research.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
7
Inclusion Criteria

Not provided

Exclusion Criteria

1. paroxysmal atrial fibrillation 2. valvular disease 3. heart diseases (heart failure, myocardial infarction, angina) 4. hyperthyroidism 5. left atrial with a diameter over 50 mm 6. evident infection or inflammatory disease 7. history of participation to study using adrenomedullin 8. untreated proliferative diabetic retinopathy 9. history of cardiovascular accident within 3 months 10. serious complications (renal insufficiency, liver damage, uncontrolled diabetes, uncontrolled hypertension) 11. malignancy or history of therapy for malignancy 12. pregnancy, lactating 13. other reason depend on the decision of investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath